Tatevik Ohanyan

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Elevated baseline soluble FcεRI may be linked to early response to omalizumab treatment in chronic spontaneous urticaria.

Elevated baseline soluble FcεRI may be linked to early response to omalizumab treatment in chronic spontaneous urticaria.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: March 17, 2023

The response to treatment in chronic spontaneous urticaria depends on how it is measured.

The response to treatment in chronic spontaneous urticaria depends on how it is measured.

Journal: The journal of allergy and clinical immunology. In practice

Published: November 23, 2018

Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab.

Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab.

Journal: Allergy

Published: August 05, 2018

Real-life treatment of cholinergic urticaria with omalizumab.

Real-life treatment of cholinergic urticaria with omalizumab.

Journal: The Journal of allergy and clinical immunology

Published: April 13, 2018

Development of tripe palms and soles in a patient with long pre-existing systemic mastocytosis and newly developed non-small cell lung cancer.

Development of tripe palms and soles in a patient with long pre-existing systemic mastocytosis and newly developed non-small cell lung cancer.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: October 22, 2017

Role of Substance P and Its Receptor Neurokinin 1 in Chronic Prurigo: A Randomized, Proof-of-Concept, Controlled Trial with Topical Aprepitant.

Role of Substance P and Its Receptor Neurokinin 1 in Chronic Prurigo: A Randomized, Proof-of-Concept, Controlled Trial with Topical Aprepitant.

Journal: Acta dermato-venereologica

Published: August 31, 2017

Comparison and interpretability of the available urticaria activity scores.

Comparison and interpretability of the available urticaria activity scores.

Journal: Allergy

Published: August 11, 2017

The Urticaria Activity Score-Validity, Reliability, and Responsiveness.

The Urticaria Activity Score-Validity, Reliability, and Responsiveness.

Journal: The journal of allergy and clinical immunology. In practice

Published: April 20, 2017

Responsiveness and minimal important difference of the urticaria control test.

Responsiveness and minimal important difference of the urticaria control test.

Journal: The Journal of allergy and clinical immunology

Published: July 27, 2016

Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria.

Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria.

Journal: The Journal of allergy and clinical immunology

Published: February 09, 2016

Increased angiogenesis and VEGF expression correlates with disease severity in prurigo patients.

Increased angiogenesis and VEGF expression correlates with disease severity in prurigo patients.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: May 11, 2015

Omalizumab may not inhibit mast cell and basophil activation in vitro.

Omalizumab may not inhibit mast cell and basophil activation in vitro.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: May 09, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026